1e
19
1
49
2
2
18
1b
1d
18
34
7c
1d
2 29
1d
25
Timothy Olson, MD, PhD
88
7c
Associate Professor of Pediatrics (Oncology) at the Children's Hospital of Philadelphia
28
cd
3
61
Attending Physician, Comprehensive Bone Marrow Failure Center, Division of Hematology, Children's Hospital of Philadelphia, University of Pennsylvania
90
Attending Physician, Children's Hospital of Philadelphia Cell Therapy and Transplant Section,
48
Children’s Hospital of Philadelphia, University of Pennsylvania
84
Member, Abramson Cancer Center, University of Pennsylvania School of Medicine
c5
Principal Investigator Bone Marrow Failure Registry and Sample Repository, Children's Hospital of Philadelphia and University of Pennsylvania
ae
Clinical Co-Director, Center for Curative Therapies for Red Cell Disorders program, Children's Hospital of Philadlephia
a4
Medical Director, Hematopoietic Stem Cell Transplantation (HSCT) Program, Children's Hospital of Philadelphia
d1
Associate Section Chief, Cell Therapy and Transplant Section, Division of Pediatric Oncology, Department of Pediatrics Children's Hospital of Philadelphia
87
Director, Children's Hospital of Philadelphia Team Telomere Center of Excellence
11
Department: Pediatrics
4
1
b
1d
46
Contact information
53
4
3
3
3
2
4
b
1f
53
Children’s Hospital of Philadelphia
38 Colket Translational Research Building Room 3010
39 3501 Civic Center BLVD
Philadelphia, PA 19104
26
38 Colket Translational Research Building Room 3010
39 3501 Civic Center BLVD
Philadelphia, PA 19104
2e
Office: 267-426-5516
30
7f
30
Email:
olsont@chop.edu
12
olsont@chop.edu
13
Education:
21 7 BA 3a (Biochemistry and Cell Biology; Policy Studies) c
28 Rice University, 1998.
21 8 PhD 21 (Molecular Physiology) c
33 The University of Virginia, 2005.
21 7 MD 15 (Medicine) c
33 The University of Virginia, 2006.
c
3
3
3
3
8d
Permanent link21 7 BA 3a (Biochemistry and Cell Biology; Policy Studies) c
28 Rice University, 1998.
21 8 PhD 21 (Molecular Physiology) c
33 The University of Virginia, 2005.
21 7 MD 15 (Medicine) c
33 The University of Virginia, 2006.
c
2 29
21
1e
1d
24
5e
25 Bone marrow failure syndromes
35 Clonal hematopoietic evolution/myelodysplasia
50 T cell Depletion strategies for SCT in Non-malignant hematologic diseases
65
25 Inherited bone marrow failure
23 SCT for bone marrow failure
22 SCT for hemoglobinopathies
2a Gene therapy for hemoglobinopathies
1a 7 1d 1f
27
Description of Research Expertise
4c Stem Cell Engraftment Following Bone Marrow Transplantation25 Bone marrow failure syndromes
35 Clonal hematopoietic evolution/myelodysplasia
50 T cell Depletion strategies for SCT in Non-malignant hematologic diseases
65
Description of Clinical Expertise
29 Acquired Aplastic Anemia25 Inherited bone marrow failure
23 SCT for bone marrow failure
22 SCT for hemoglobinopathies
2a Gene therapy for hemoglobinopathies
1a 7 1d 1f